InvestorsObserver is giving Livongo Health Inc (LVGO) an Analyst Rating Rank of 77, meaning LVGO is ranked higher by analysts than 77% of stocks. The average projection by analysts for LVGO is $90.071 over the next 12 months and analyst’s classify the stock as a Strong Buy
Why are Analyst Ratings Important?
Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported.
Investors Observer takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.
What's Happening With Livongo Health Inc Stock Today?
Livongo Health Inc (LVGO) stock has risen 3.72% while the S&P 500 is down -0.13% as of 9:47 AM on Thursday, Aug 6. LVGO is up $4.76 from the previous closing price of $128.06 on volume of 643,118 shares. Over the past year the S&P 500 is up 15.23% while LVGO is up 299.94%. LVGO lost -$0.36 per share the over the last 12 months.
